@bread89
Fair enough, point taken. Guesses without any research below.
USD200 - USD300m of annual revenue if they were successful across 1, 2, 3, 4 above
10% market share in US and an additional USD100m of revenue elsewhere
15x sales for price to sales ~ which is about what it is now (and the avg. for the peers in the market)
Some dilution for capital raises, risks on product market entry,and lower price to sales for more mature companies.
$3 - $6 share price.
What are your guesses?
- Forums
- ASX - By Stock
- Broker analysis
@bread89Fair enough, point taken. Guesses without any research...
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.65 |
Change
-0.020(0.75%) |
Mkt cap ! $159.5M |
Open | High | Low | Value | Volume |
$2.68 | $2.70 | $2.63 | $496.8K | 185.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 8481 | $2.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.68 | 13000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8481 | 2.650 |
1 | 5092 | 2.640 |
4 | 10466 | 2.630 |
1 | 1000 | 2.620 |
8 | 9040 | 2.610 |
Price($) | Vol. | No. |
---|---|---|
2.680 | 13000 | 2 |
2.690 | 86 | 1 |
2.700 | 8409 | 2 |
2.720 | 1000 | 1 |
2.730 | 950 | 2 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$2.66 |
  |
Change
-0.020 ( 0.15 %) |
|||
Open | High | Low | Volume | ||
$2.69 | $2.70 | $2.64 | 11993 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
AVH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online